Literature DB >> 29275445

Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5.

Kazuyoshi Ogasawara1,2, Yukako Nakamura3, Hiroyuki Kimura3, Branko Aleksic3, Norio Ozaki3.   

Abstract

The authors present a narrative review from the diagnostic and nosologic viewpoints of mood disorders (bipolar and depressive ones) by revisiting the revision from the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders, Text Revision to DSM-5, including the following: the separation of the bipolar and depressive sections; the addition of increased energy and continuation of symptoms to the hypo/manic criteria; the elimination of mixed episodes; the creation of new categories and specifiers ("other specified bipolar and related disorder", "disruptive mood dysregulation disorder", "with anxious distress", "with mixed features", "with peripartum onset"); the categorization of hypo/manic episodes during antidepressant treatment into bipolar disorder; the elimination of the "bereavement exclusion"; the ambiguous separation between bipolar I and II; the insufficient distinction between "other specified bipolar and related disorders" and major depressive disorder; the differentiation regarding borderline personality disorder; agitation; premenstrual dysphoric disorder; and society and psychiatry. Through this analysis, we point out both the achievements and limitations of DSM-5. In addition, to examine the future direction of psychiatry, we introduce our cohort study regarding maternal depression and an outline of the National Institute of Mental Health's Research Domain Criteria project in the US. Finally, we advocate the importance of elucidating etiopathogeneses by starting from or going beyond the DSM operational diagnostic system, which has shown great efficacy.

Entities:  

Keywords:  Bipolar and related disorders; DSM-5; Depressive disorders; Diagnosis; Mood disorders; RDoC

Mesh:

Year:  2017        PMID: 29275445     DOI: 10.1007/s00702-017-1828-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  75 in total

Review 1.  Premenstrual Dysphoric Disorder.

Authors:  Teresa Lanza di Scalea; Teri Pearlstein
Journal:  Psychiatr Clin North Am       Date:  2017-03-01

Review 2.  A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders.

Authors:  Marco Solmi; Leonardo Zaninotto; Tommaso Toffanin; Nicola Veronese; Kangguang Lin; Brendon Stubbs; Michele Fornaro; Christoph U Correll
Journal:  J Affect Disord       Date:  2016-02-12       Impact factor: 4.839

3.  Disruptive Mood Dysregulation Disorder and Bipolar Disorder Not Otherwise Specified: Fraternal or Identical Twins?

Authors:  Mary A Fristad; Hannah Wolfson; Guillermo Perez Algorta; Eric A Youngstrom; L Eugene Arnold; Boris Birmaher; Sarah Horwitz; David Axelson; Robert A Kowatch; Robert L Findling
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-02-09       Impact factor: 2.576

4.  The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention.

Authors:  Judit Balázs; Franco Benazzi; Zoltán Rihmer; Annamária Rihmer; K K Akiskal; H S Akiskal
Journal:  J Affect Disord       Date:  2006-02-03       Impact factor: 4.839

Review 5.  Reward processing and mood-related symptoms: An RDoC and translational neuroscience perspective.

Authors:  Robin Nusslock; Lauren B Alloy
Journal:  J Affect Disord       Date:  2017-02-04       Impact factor: 4.839

6.  The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11.

Authors:  J Phelps; S N Ghaemi
Journal:  Acta Psychiatr Scand       Date:  2012-08-17       Impact factor: 6.392

7.  DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.

Authors:  Darrel A Regier; William E Narrow; Diana E Clarke; Helena C Kraemer; S Janet Kuramoto; Emily A Kuhl; David J Kupfer
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112

Review 8.  The genetics of major depression.

Authors:  Jonathan Flint; Kenneth S Kendler
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

9.  Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.

Authors:  S G Fillman; D Sinclair; S J Fung; M J Webster; C Shannon Weickert
Journal:  Transl Psychiatry       Date:  2014-02-25       Impact factor: 6.222

10.  Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.

Authors:  S H Witt; F Streit; M Jungkunz; J Frank; S Awasthi; C S Reinbold; J Treutlein; F Degenhardt; A J Forstner; S Heilmann-Heimbach; L Dietl; C E Schwarze; D Schendel; J Strohmaier; A Abdellaoui; R Adolfsson; T M Air; H Akil; M Alda; N Alliey-Rodriguez; O A Andreassen; G Babadjanova; N J Bass; M Bauer; B T Baune; F Bellivier; S Bergen; A Bethell; J M Biernacka; D H R Blackwood; M P Boks; D I Boomsma; A D Børglum; M Borrmann-Hassenbach; P Brennan; M Budde; H N Buttenschøn; E M Byrne; P Cervantes; T-K Clarke; N Craddock; C Cruceanu; D Curtis; P M Czerski; U Dannlowski; T Davis; E J C de Geus; A Di Florio; S Djurovic; E Domenici; H J Edenberg; B Etain; S B Fischer; L Forty; C Fraser; M A Frye; J M Fullerton; K Gade; E S Gershon; I Giegling; S D Gordon; K Gordon-Smith; H J Grabe; E K Green; T A Greenwood; M Grigoroiu-Serbanescu; J Guzman-Parra; L S Hall; M Hamshere; J Hauser; M Hautzinger; U Heilbronner; S Herms; S Hitturlingappa; P Hoffmann; P Holmans; J-J Hottenga; S Jamain; I Jones; L A Jones; A Juréus; R S Kahn; J Kammerer-Ciernioch; G Kirov; S Kittel-Schneider; S Kloiber; S V Knott; M Kogevinas; M Landén; M Leber; M Leboyer; Q S Li; J Lissowska; S Lucae; N G Martin; F Mayoral-Cleries; S L McElroy; A M McIntosh; J D McKay; A McQuillin; S E Medland; C M Middeldorp; Y Milaneschi; P B Mitchell; G W Montgomery; G Morken; O Mors; T W Mühleisen; B Müller-Myhsok; R M Myers; C M Nievergelt; J I Nurnberger; M C O'Donovan; L M O Loohuis; R Ophoff; L Oruc; M J Owen; S A Paciga; B W J H Penninx; A Perry; A Pfennig; J B Potash; M Preisig; A Reif; F Rivas; G A Rouleau; P R Schofield; T G Schulze; M Schwarz; L Scott; G C B Sinnamon; E A Stahl; J Strauss; G Turecki; S Van der Auwera; H Vedder; J B Vincent; G Willemsen; C C Witt; N R Wray; H S Xi; A Tadic; N Dahmen; B H Schott; S Cichon; M M Nöthen; S Ripke; A Mobascher; D Rujescu; K Lieb; S Roepke; C Schmahl; M Bohus; M Rietschel
Journal:  Transl Psychiatry       Date:  2017-06-20       Impact factor: 6.222

View more
  6 in total

1.  Recent Findings of the Comparative Efficacy and Tolerability of Antidepressants for Major Depressive Disorder: Do We Now Know What to Prescribe?

Authors:  Matthew V Rudorfer
Journal:  CNS Drugs       Date:  2018-09       Impact factor: 5.749

2.  An AI-based Decision Support System for Predicting Mental Health Disorders.

Authors:  Salih Tutun; Marina E Johnson; Abdulaziz Ahmed; Abdullah Albizri; Sedat Irgil; Ilker Yesilkaya; Esma Nur Ucar; Tanalp Sengun; Antoine Harfouche
Journal:  Inf Syst Front       Date:  2022-05-28       Impact factor: 5.261

3.  Development of the 12-item questionnaire for quantitative assessment of depressive mixed state (DMX-12).

Authors:  Hotaka Shinzato; Munenaga Koda; Akifumi Nakamura; Tsuyoshi Kondo
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-15       Impact factor: 2.570

Review 4.  Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges.

Authors:  Gianna Sepede; Marcella Brunetti; Massimo Di Giannantonio
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-10       Impact factor: 2.570

Review 5.  Is Vitamin D Important in Anxiety or Depression? What Is the Truth?

Authors:  Şerife Akpınar; Makbule Gezmen Karadağ
Journal:  Curr Nutr Rep       Date:  2022-09-13

6.  Extracellular Vesicles in Psychiatry Research in the Context of RDoC Criteria.

Authors:  Can Ilgın; Ahmet Topuzoğlu
Journal:  Psychiatry Investig       Date:  2018-11-02       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.